{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:14:25Z","timestamp":1783469665651,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cervical lymph node metastasis assessment determines treatment strategy and prognosis in head and neck squamous cell carcinoma (HNC). PET\/CT is the standard staging modality but suffers from high false-positive (FP) rates with a substantial portion of imaging-suspicious nodes proving pathologically negative. A fundamental knowledge gap persists; whether imaging positivity itself, despite ultimate pathologic negativity, provides prognostic significance sufficient to justify treatment escalation. This study directly answers this critical clinical question by comparing prognostic outcomes between patients with imaging-positive-but-pathology-negative nodes (FP) and those with concordantly imaging-negative nodes (TN), determining whether the additional imaging positivity differential translates into measurable survival or recurrence disparities. A total of 176 newly diagnosed HNC patients from the ACRIN 6685 cohort undergoing PET\/CT staging with complete pathologic confirmation were included. Patients were stratified into FP and TN groups. Cox and competing-risk regression analyses compared recurrence-free survival, overall survival, and HNC-specific survival between two cohorts, adjusted for potential prognostic confounders. Among 176 patients, 137 (77.8%) demonstrated FP findings on PET. Imaging positivity provided no prognostic value; FP and TN cohorts showed equivalent overall survival and HNSCC-specific mortality. Quantitative PET nodal burden (number of suspicious lymph node levels) minimal recurrence association (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.013), but binary nodal presence did not. Imaging positivity alone, when pathology is negative, does not predict worse outcomes. This imaging-pathology discordance carries no prognostic penalty, allowing clinicians to base treatment decisions and prognostic counseling on surgical pathology results rather than escalating care based solely on imaging appearance.\n                  <\/jats:p>\n                  <jats:p>\u200b.<\/jats:p>","DOI":"10.1038\/s41598-026-51823-1","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:06:30Z","timestamp":1778209590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of PET\/CT false-positive cervical lymph nodes in head and neck cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Alisa","family":"Mohebbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"1","key":"51823_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/lary.29674","volume":"132","author":"TY Tsai","year":"2022","unstructured":"Tsai, T. Y. et al. The Prognostic Value of Lymph Node Burden in Oral Cavity Cancer: Systematic Review and Meta-Analysis. Laryngoscope 132 (1), 88\u201395 (2022).","journal-title":"Laryngoscope"},{"issue":"2","key":"51823_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2478\/raon-2018-0020","volume":"52","author":"C Eder-Czembirek","year":"2018","unstructured":"Eder-Czembirek, C. et al. Comparative Analysis of Clinical and Pathological Lymph Node Staging Data in Head and Neck Squamous Cell Carcinoma Patients Treated at the General Hospital Vienna. Radiol. Oncol. 52 (2), 173\u2013180 (2018).","journal-title":"Radiol. Oncol."},{"issue":"1","key":"51823_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1186\/s12885-025-14232-7","volume":"25","author":"A Navran","year":"2025","unstructured":"Navran, A. et al. Postoperative complications following salvage neck dissection after (chemo)radiotherapy for head and neck squamous cell carcinoma: which patients are at high risk? BMC Cancer. 25 (1), 823 (2025).","journal-title":"BMC Cancer"},{"issue":"2","key":"51823_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00405-025-09887-8","volume":"283","author":"M Fermi","year":"2026","unstructured":"Fermi, M. et al. Survival rates in head and neck cutaneous squamous cell carcinoma with nodal metastases: a multicenter study. Eur. Arch. Otorhinolaryngol. 283 (2), 1099\u20131109 (2026).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"1","key":"51823_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.rcl.2025.06.003","volume":"64","author":"PP Batchala","year":"2026","unstructured":"Batchala, P. P. & Raghavan, P. 18-FDG-PET Imaging in Head and Neck Cancer: Current Application. Radiol. Clin. North. Am. 64 (1), 51\u201362 (2026).","journal-title":"Radiol. Clin. North. Am."},{"key":"51823_CR6","doi-asserted-by":"crossref","unstructured":"Caldarella, C. et al. Role of (18)F-FDG PET\/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications. Cancers (Basel), 16(10). (2024).","DOI":"10.3390\/cancers16101905"},{"key":"51823_CR7","doi-asserted-by":"crossref","unstructured":"Guedj, D. et al. FDG PET-CT for the Detection of Occult Nodal Metastases in Head and Neck Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel), 16(17). (2024).","DOI":"10.3390\/cancers16172954"},{"issue":"6","key":"51823_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1177\/0194599820969104","volume":"164","author":"BC Stack Jr","year":"2021","unstructured":"Stack, B. C. Jr. et al. FDG-PET\/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET\/CT cN0. Otolaryngol. Head Neck Surg. 164 (6), 1230\u20131239 (2021).","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"20","key":"51823_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1200\/JCO.18.01182","volume":"37","author":"VJ Lowe","year":"2019","unstructured":"Lowe, V. J. et al. Multicenter Trial of [(18)F]fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685. J. Clin. Oncol. 37 (20), 1704\u20131712 (2019).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"51823_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/hed.27239","volume":"45","author":"C Giannitto","year":"2023","unstructured":"Giannitto, C. et al. Radiomics-based machine learning for the diagnosis of lymph node metastases in patients with head and neck cancer: Systematic review. Head Neck. 45 (2), 482\u2013491 (2023).","journal-title":"Head Neck"},{"key":"51823_CR11","doi-asserted-by":"crossref","unstructured":"Jiang, S. et al. Radiomics-Based Analysis in the Prediction of Occult Lymph Node Metastases in Patients with Oral Cancer: A Systematic Review. J. Clin. Med., 12(15). (2023).","DOI":"10.3390\/jcm12154958"},{"key":"51823_CR12","doi-asserted-by":"publisher","first-page":"107821","DOI":"10.1016\/j.oraloncology.2025.107821","volume":"172","author":"F Chiari","year":"2026","unstructured":"Chiari, F. et al. Survival rates and oncologic outcomes of adeno squamous carcinoma of oral cavity: A systematic review. Oral Oncol. 172, 107821 (2026).","journal-title":"Oral Oncol."},{"key":"51823_CR13","first-page":"102001","volume":"42","author":"SJ Vastrad","year":"2025","unstructured":"Vastrad, S. J. et al. A comprehensive transcriptome based meta-analysis to unveil the aggression nexus of oral squamous cell carcinoma. Biochem. Biophys. Rep. 42, 102001 (2025).","journal-title":"Biochem. Biophys. Rep."},{"issue":"1","key":"51823_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40644-020-00334-x","volume":"20","author":"O Freihat","year":"2020","unstructured":"Freihat, O. et al. Diffusion-Weighted Imaging (DWI) derived from PET\/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC). Cancer Imaging. 20 (1), 56 (2020).","journal-title":"Cancer Imaging"},{"issue":"6","key":"51823_CR15","doi-asserted-by":"publisher","first-page":"734","DOI":"10.37349\/etat.2022.00110","volume":"3","author":"MP Belfiore","year":"2022","unstructured":"Belfiore, M. P. et al. Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review. Explor. Target. Antitumor Ther. 3 (6), 734\u2013745 (2022).","journal-title":"Explor. Target. Antitumor Ther."},{"key":"51823_CR16","doi-asserted-by":"crossref","unstructured":"Alsibani, A. et al. Comparing the Efficacy of CT, MRI, PET-CT, and US in the Detection of Cervical Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma with Clinically Negative Neck Lymph Node: A Systematic Review and Meta-Analysis. J Clin Med, 13(24). (2024).","DOI":"10.3390\/jcm13247622"},{"issue":"8","key":"51823_CR17","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1097\/JS9.0000000000001578","volume":"110","author":"T Lan","year":"2024","unstructured":"Lan, T. et al. MRI-based deep learning and radiomics for prediction of occult cervical lymph node metastasis and prognosis in early-stage oral and oropharyngeal squamous cell carcinoma: a diagnostic study. Int. J. Surg. 110 (8), 4648\u20134659 (2024).","journal-title":"Int. J. Surg."},{"issue":"12","key":"51823_CR18","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1007\/s00405-025-09707-z","volume":"282","author":"DM Filippini","year":"2025","unstructured":"Filippini, D. M. et al. Challenges in pathological diagnosis of rare head and neck cancers: National survey and retrospective study. Eur. Arch. Otorhinolaryngol. 282 (12), 6465\u20136475 (2025).","journal-title":"Eur. Arch. Otorhinolaryngol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51823-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:27:52Z","timestamp":1783466872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51823-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51823"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51823-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This post-hoc analysis was conducted using data from the American College of Radiology Imaging Network (ACRIN) 6685 prospective multicenter cohort study. The original study was approved by the institutional review boards of all 24 participating centers in the United States, and written informed consent was obtained from all participants. The current analysis utilized fully de-identified data; therefore, further ethical approval or additional consent requirements were waived by the local institutional review board of Urmia University of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate declarations"}}],"article-number":"21084"}}